Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the
Comcast logo on the wall of a building at Universal Studios in Orlando, Florida, July 18, 2019. Roberto Machado Noa | Lightrocket | Getty Images Analysts think Comcast is priming for deals. Comcast leadership says they're wrong. The company announced Monday it plans to separate its two primary businesses — cable broadband and the media
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate reviews of new domestic pharmaceutical manufacturing facilities, CNBC has learned. Lilly, Regeneron, Amneal , Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in the